Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportunities for consumable providers having capabilities for raw material production. London Roots Analysis has announced the addition of the “Cell Therapy Consumables Market” report to its list of […]
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market. Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, […]
Notice: Due to rising maintenance costs, only paid articles will be kept permanent, free articles will be deleted after 30 days.